Medicare Advantage and Prescription Drug Plans December 28 ...

More documents

Recommendations

Info

Plan Communications User Guide Appendices, Version 6.3 Item Field Size Position Comment Description 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 Age Group Male90_94 Age Group Male95_GT Originally Disabled Female Originally Disabled Male Disease Coefficients RXHCC1 Disease Coefficients RXHCC5 Disease Coefficients RXHCC8 Disease Coefficients RXHCC9 Disease Coefficients RXHCC10 Disease Coefficients RXHCC11 Disease Coefficients RXHCC14 Disease Coefficients RXHCC15 Disease Coefficients RXHCC18 Disease Coefficients RXHCC19 Disease Coefficients RXHCC20 1 74 1 75 1 76 1 77 1 78 1 79 1 80 1 81 1 82 1 83 1 84 1 85 1 86 1 87 1 88 Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" The sex and age group for the beneficiary based on a given as of date. Male between ages of 90 and 94, inclusive. The sex and age group for the beneficiary based on a given as of date. Male, age 95 and greater. Beneficiary is a female and original Medicare entitlement was due to disability. Beneficiary is a male and original Medicare entitlement was due to disability. HIV/AIDS Opportunistic Infections Chronic Myeloid Leukemia Multiple Myeloma and Other Neoplastic Disorders Breast, Lung, and Other Cancers and Tumors Prostate and Other Cancers and Tumors Diabetes with Complications Diabetes without Complication Diabetes Insipidus and Other Endocrine and Metabolic Disorders Pituitary, Adrenal Gland, and Other Endocrine and Metabolic Disorders Thyroid Disorders December 28, 2012 F-74 RAS RxHCC Model Output Data File
Plan Communications User Guide Appendices, Version 6.3 Item Field Size Position Comment Description 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Disease Coefficients RXHCC21 Disease Coefficients RXHCC23 Disease Coefficients RXHCC25 Disease Coefficients RXHCC30 Disease Coefficients RXHCC31 Disease Coefficients RXHCC32 Disease Coefficients RXHCC33 Disease Coefficients RXHCC38 Disease Coefficients RXHCC40 Disease Coefficients RXHCC41 Disease Coefficients RXHCC42 Disease Coefficients RXHCC45 Disease Coefficients RXHCC47 Disease Coefficients RXHCC48 Disease Coefficients RXHCC49 1 89 1 90 1 91 1 92 1 93 1 94 1 95 1 96 1 97 1 98 1 99 1 100 1 101 1 102 1 103 Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Set to "1" if applicable, otherwise "0" Morbid Obesity Disorders of Lipoid Metabolism Chronic Viral Hepatitis Chronic Pancreatitis Pancreatic Disorders and Intestinal Malabsorption, Except Pancreatitis Inflammatory Bowel Disease Esophageal Reflux and Other Disorders of Esophagus Aseptic Necrosis of Bone Psoriatic Arthropathy Rheumatoid Arthritis and Other Inflammatory Polyarthropathy Systemic Lupus Erythematosus, Other Connective Tissue Disorders, and Inflammatory Spondylopathies Osteoporosis, Vertebral and Pathological Fractures Sickle Cell Anemia Myelodysplastic Syndromes, Except High-Grade Immune Disorders December 28, 2012 F-75 RAS RxHCC Model Output Data File
Page 1 and 2:
Medicare Advantage and Prescription
Page 3 and 4:
Plan Communications User Guide Appe
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52: Plan Communications User Guide Appe
Page 77 and 78: F.10.3 Trailer Record Plan Communic
Page 79 and 80: F.11.2 Record Type 2 Plan Communica
Page 101: Plan Communications User Guide Appe
Page 135 and 136: F.21.2 Detail Record (Transaction)
Page 151 and 152: F.23.2 Detail Record (Transaction)
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Item # Plan Communications User Gui
Page 171 and 172:
F.28.3 Trailer Record Plan Communic
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
I.3 Obsolete Transaction Reply Code
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337 and 338:
Page 339 and 340:
Page 341 and 342:
CMS Transmittals to the Plans Plan
Page 343 and 344:
Page 345 and 346:
ID# Transmittal Monthly Transmittal
Page 347 and 348:
ID# Transmittal Monthly Transmittal
Page 349 and 350:
Page 351 and 352:
Page 353 and 354:
Page 355 and 356:
show all

Medicare Advantage and Prescription Drug Plans December 28 ...

Create successful ePaper yourself

Delete template?

Save as template?